Publications

5677 Results

EA-2186: A randomized phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5- Fluorouracil, Leucovorin, and Liposomal Irinotecan in older patients with treatment naïve metastatic pancreatic cancer (GIANT): Trials in Progress

Authors
E Dotan;P Catalano;L Lenchik;R Boutin;X Yao;C Gatsonis;D Zhen;D Li;L Wagner;M Simon;T Wong;P O'Dwyer
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr TPS4185), poster 157B; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/EA2186

A Phase II/III Trial of Chemotherapy + Cetuximab vs. Chemotherapy + Bevacizumab vs. Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers: ECOG-ACRIN EA3202

Authors
A Bhatia;Y Flamand;J Johnson;J Ishizuka;F Duan;M Tang;V Karivedu;R Subramaniam;B Burtness
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr TPS6098), poster 89A; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Early Therapeutics and Rare Cancers

A Phase III Double Blinded Study of Early Intervention After RADICAl ProstaTEctomy With Androgen Deprivation Therapy With Darolutamide vs. Placebo in Men at Highest Risk of Prostate Cancer Metastasis by Genomic Stratification (ERADICATE)

Authors
A Morgans;Y Chen;A Ferrari;P Tran;E Schaeffer;D Shevrin;R Szmulewitz;T Boike;T Dorff;G Liu;L Wagner;M Carducci
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr TPS4617), poster #98B; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Genitourinary

EA8185: Phase 2 Study of Bladder-SparIng ChemoradiatioN (chemoRT) with Durvalumab in Clinical Stage III, Node PosItive URothElial Carcinoma (INSPIRE), an ECOG-ACRIN/NRG Collaboration

Authors
M Joshi;S Kim;A Solanki;D Miyamoto;D Degraff;J Zou;J Meeks;T Mitin;S Collins;E Trabulsi;N Hahn;J Efstathiou;M Carducci
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr TPS4617), poster 98B; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/EA8185

Improving Patient Advocacy in NCI Scientific Steering Committees and Task Forces

Authors
R Bangs;J Lynn;E Obot;S Osborne;K Norris
Journal / Conference
Journal of the National Cancer Institute Aug 8;114(8):1059-1064
Year
2022
Research Committee(s)
Cancer Care Delivery
PMID
PMID35552713
PMC
PMC9360467

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small Cell Lung Cancer Previously Treated with Immunotherapy—Lung-MAP S1800A

Authors
K Reckamp;M Redman;K Dragnev;L Villaruz;B Faller;T Al Baghdadi;S Hines;L Everhart;L Highleyman;K Minichiello;V Papadimitrakopoulou;J Neal;S Waqar;S Waqar;J Patel;J Gray;D Gandara;K Kelly;R Herbst
Journal / Conference
Journal of Clinical Oncology Jul 20;40(21):2295-2306
Year
2022
Research Committee(s)
Lung
PMID
PMID35658002
PMC
PMC9287284
Study Number(s)
S1800A

Randomized Phase II Trial Of Gemcitabine, Avelumab and Carboplatin vs. No Neoadjuvant Therapy Preceding Surgery for Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma (MIUC): SWOG Gap Trial (S2011)

Authors
G Sonpavde;M Plets;M Liss;J Meeks;D Petrylak;S Cole;R McKay;S Gupta;S Hita;T Pereira;R Bangs;C Tangen;IM Thompson;SP Lerner
Journal / Conference
JCO Vol 40 Issue 6 Supp; ASCO Genitourinary (GU) Cancers Symposium 2022 (Feb 17-19, 2022, San Francisco, CA), poster
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S2011

Orteronel for metastatic hormone sensitive prostate cancer: A multicenter, randomized, open-label phase III trial (SWOG-1216)

Authors
N Agarwal;C Tangen;M Hussain;S Gupta;M Plets;P Lara;A Harzstark;P Twardowski;C Paller;D Zylla;M Zibelman;E Levine;B Roth;A Goldkorn;D Vaena;M Kohli;A Crispino;N Vogelzang;IM Thompson;DI Quinn
Journal / Conference
Journal of Clinical Oncology Oct 1;40(28):3301-3309
Year
2022
Research Committee(s)
Genitourinary
PMID
PMID35446628
PMC
PMC9553390
Study Number(s)
S1216

A More Efficient Approach to Clinical Trial Data Collection: The SWOG-nCartes Pilot Collaboration

Authors
C Cook;D Weatherbee;A Smith;S Yadav;G Bhardwaj;J Mcllwain;A Hoering;M LeBlanc;K Goodman
Journal / Conference
Society for Clinical Trials (MAY 15-18, 2022 San Diego, CA), poster
Year
2022
Research Committee(s)
Multiple sites

Lessons from Implementing Practice-Level Cluster Randomized Studies within the NCORP Setting

Authors
K Arnold;G Anderson;D Weatherbee
Journal / Conference
Society for Clinical Trials (MAY 15-18, 2022 San Diego, CA), poster
Year
2022
Research Committee(s)
Cancer Care Delivery, Prevention, Screening, and and Surveillance
Study Number(s)
S1415CD, S1904, S2108CD